Trial intelligence / Profile preview

IX-01 in lifelong premature ejaculation

NCT02232425Phase 2Completed

Sponsor
Ixchelsis
Start
Sep 2014
Primary completion
Oct 2015
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of cligosiban in premature ejaculation (PE), sponsored by Ixchelsis. Started Sep 2014; status: completed.

02

Drugs

cligosiban
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on NCT02232425.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02232425.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call